multiplex PCR
The firm said a test it has developed on the back of a large clinical trial detected cardioembolic stroke with 90 percent sensitivity and 70 percent specificity.
The firm also recently validated its instrument-agnostic technology's ability to detect up to 20 targets per qPCR well using high-definition PCR.
BioFire Dx Receives First FDA Marketing Clearance for SARS-CoV-2 Respiratory Panel
The test is the first COVID-19 assay to transition from Emergency Use Authorization to a cleared regulatory status.
LexaGene Open-Access Syndromic Panel Platform Lets Labs Customize Targets, Including SARS-CoV-2
Premium
The MiQLab system can look for 27 different targets, allowing the detection of SARS-CoV-2 as well as the determination of specific variants.
Anitoa Systems Gets CE-IVD Mark for Portable qPCR Instrument
The Maverick instrument enables calibration-free multiplex testing in the field and is supported by cloud-based software.
Feb 6, 2020
Dec 17, 2019
ArcherDx Closes $55M Series C Financing
Dec 17, 2019
ChromaCode Raises $28M in Series C Financing
Dec 10, 2019
Mar 26, 2019
CareDx, Stanford Sue Natera for Patent Infringement
Jan 30, 2019